Related Experiment Video

Updated: Aug 12, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Pneumococcal conjugate vaccines - implications for community antibiotic prescribing

T Q Tan1

  • 1Northwestern University Medical School, Division of Infectious Diseases, The Children's Memorial Hospital, 2300 Children's Plaza, Box 20, Chicago, IL 60614, USA. ttan@nwu.edu

Current Opinion in Microbiology
|October 26, 2000
PubMed

Insights

Pneumococcal conjugate vaccines are crucial for preventing serious infections in children. These vaccines offer a safe and effective way to combat rising antibiotic resistance in Streptococcus pneumoniae.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Microbiology

Background:

  • Streptococcus pneumoniae infections cause significant global pediatric morbidity and mortality.
  • Increasing antibiotic resistance complicates treatment of pneumococcal infections.
  • Existing polysaccharide vaccines are ineffective in infants and young children.

Purpose of the Study:

  • To highlight the importance of developing safe and effective pneumococcal vaccines for children.
  • To address the limitations of current vaccines against Streptococcus pneumoniae.

Main Methods:

  • Review of existing literature on Streptococcus pneumoniae epidemiology and vaccine efficacy.
  • Analysis of the immunogenicity and effectiveness of pneumococcal vaccines in pediatric populations.

Main Results:

  • The 23-valent pneumococcal polysaccharide vaccine shows poor immunogenicity in infants.
  • Pneumococcal conjugate vaccines have demonstrated safety and efficacy in pediatric populations.

Conclusions:

  • Pneumococcal conjugate vaccines are essential for reducing the burden of pediatric pneumococcal disease.
  • Development and widespread use of these vaccines are critical public health interventions.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...